MagForce AG (BST: MF6)
Germany
· Delayed Price · Currency is EUR
0.0010
0.00 (0.00%)
At close: Nov 22, 2024
MagForce AG Company Description
MagForce AG develops advanced nanomedicine for cancer therapies.
It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator.
MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
MagForce AG
Country | Germany |
Founded | 1997 |
Industry | Biological Products, Except Diagnostic Substances |
Employees | 33 |
CEO | Benjamin Lipps |
Contact Details
Address: Max-Planck-Straße 3 Berlin, 12489 Germany | |
Phone | 49 30 308 380 0 |
Website | magforce.de |
Stock Details
Ticker Symbol | MF6 |
Exchange | Stuttgart Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | EUR |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Benjamin Lipps | Chief Executive Officer |
Barbara Frankenberg | Head of Investor Relations |